Schonfeld Strategic Advisors »

Eyepoint Pharmaceuticals shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $12M 662k 18.27
2024-12-31 $91k 12k 7.45
2024-06-30 $885k 102k 8.70
2023-09-30 $303k 38k 7.99
2022-12-31 $36k 10k 3.50
2020-12-31 $71k 11k 6.64

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr China Lg-cap Etf (FXI)
Microsoft Corporation (MSFT)
Tesla Motors (TSLA)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ishares Ethereum Tr SHS (ETHA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Spdr Series Trust State Street Spd Call Option (KRE)

View all positions for Schonfeld Strategic Advisors

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
BlackRock
Federated Investors
Adage Capital Partners GP
Franklin Resources
Vanguard Group
Paradigm Biocapital Advisors
TCG Crossover Management
OrbiMed Advisors
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen
Goldman Sachs Group

View all funds holding Eyepoint Pharmaceuticals